Sandoz files U.S. antitrust lawsuit against Amgen over arthritis drug

Swiss generic drug manufacturer Sandoz (SIX:SDZ) said on Monday it had filed an antitrust lawsuit in the United States against Amgen (NASDAQ:AMGN) over the alleged entrenchment of the market position of its blockbuster medicine, Enbrel (etanercept).